Table 1.
Patient number | Age | PSA at the time of PET/MRI | Gleason score | miTNM classification (according to Eiber M 2018) | Visual PI-RADS |
DL-PI-RADS | DICE coefficient (T2w + ADC union) | Applied [18F]-PSMA-1007 activity (MBq) |
---|---|---|---|---|---|---|---|---|
1 | 77 | 18.9 | 9 | T4, N1b, M1b | 5 | 0.993 = 5 | 0.441 | 166 |
2 | 55 | 63.8 | 7b | T3b, N1b, M0 | 5 | 0.988 = 5 | 0.433 | 239 |
3 | 64 | 5.2 | 9 | T2u, N0, M0 | 5 | 0.999 = 5 | 0.696 | 194 |
4 | 72 | 5.4 | 9 | T2u, N0, M0 | 5 | 0.949 = 5 | 0.561 | 176 |
5 | 48 | 4.0 | 6 | T0, N0, M0 | 2 | 0.05 = 2 | - | 241 |
6 | 69 | 33.2 | 9 | T3b, N1a, M0 | 5 | 0.42 = 4 | 0.139 | 229 |
7 | 70 | 63.0 | 9 | T3b, N1b, M1b | 5 | 0.45 = 4 | 0.382 | 242 |
miTNM, molecular imaging TNM; PI-RADS, Prostate Imaging Reporting and Data System; DL, deep learning; T2w, T2-weighted image; ADC, apparent diffusion coefficient; DICE, coefficient according to (Dice 1945)